ArticleFrontiers in immunology2023

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).

Luigi Gargiulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.